Clinical Trials Browser

Phase 1/2 × Keratosis, Actinic × 1-phenyl-3,3-dimethyltriazene × Clear all

NCT06712381 2024-12-02

Carac & PDT Combination in the Treatment Of Actinic Keratoses

Phase 1/2 Completed

Keratosis, Actinic